Research and Markets (http://www.researchandmarkets.com/research/de9dc9/analysis_of_oncolo) has announced the addition of the "Analysis of Oncology Deals: Trends in Deal Structures and Valuations" report to their offering.
This must-have new report, to be published shortly, contains key oncology market data, essential in answering the following questions:
- Who are the top players operating within oncology and who are the smaller companies to watch out for and partner with?
- What is the impact of the credit crunch in oncology deal making and are the emerging markets having any significant effect on this therapy area?
- Which technologies are driving the deals and why are they attractive?
It contains:
- An analysis of deal making trends and valuations by deal type, by stage of development and by territory, to provide pointers to what is likely to happen in oncology
- An analysis of royalty rates in oncology
- A comprehensive reference section with case studies of handpicked deals with analysis of SEC contracts
- Deal making activity of the top companies in oncology
Who should read this report?
- Corporate strategists and all senior managers
- Business development and deal makers
- Marketing and competitive intelligence executives
- Senior managers in R&D and technology transfer
- Analysts, consultants, venture capitalists and those within the finance sector serving the pharma and biotech industry
This report will be a standard text for all those who want to understand the trends in oncology deal structures and valuations.
Key Topics Covered:
Introduction to oncology
Overall trends in oncology deals